RACHEL BYRD: Open Payments
NPI 1861063588 · COVINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,150 in 106 payments from 8 companies in 2025. Trend: 2023 $798 · 2024 $615 · 2025 $8,150
Honoraria: $5,025Food & beverage: $1,782Travel & lodging: $1,328Education: $15
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 38 | $7,083 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 29 | $346 |
| ABBVIE INC. | 20 | $280 |
| Otsuka America Pharmaceutical, Inc. | 7 | $189 |
| Axsome Therapeutics, Inc. | 6 | $174 |
| Tris Pharma Inc | 2 | $32 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
| Corium, LLC | 2 | $15 |
Products named: Qelbree, CAPLYTA, VRAYLAR, REXULTI, Auvelity, Dyanavel XR, Jornay PM, Azstarys.
Industry payments across KY — which companies pay providers there.
